Zhende Medical Co., Ltd.

SHSE:603301 Stock Report

Market Cap: CN¥5.1b

Zhende Medical Past Earnings Performance

Past criteria checks 0/6

There is insufficient data on Zhende Medical's performance over the last few years.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Medical Equipment Industry Growth16.0%
Revenue growth raten/a
Return on equityn/a
Net Marginn/a
Next Earnings Update27 Apr 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Zhende Medical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SHSE:603301 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 225,426568916208
30 Jun 224,946489856178
31 Mar 224,362454693135
31 Dec 215,092596810153
30 Sep 216,145934839199
30 Jun 219,4911,9391,035261
31 Mar 2111,6842,7181,073296
31 Dec 2010,3992,549896260
30 Sep 208,6992,160749184
30 Jun 204,9251,085482102
31 Mar 202,24321245856
31 Dec 191,86815736351
30 Sep 191,68614032551
30 Jun 191,52613827859
31 Mar 191,48314125859
31 Dec 181,42913023357
30 Sep 181,38813521653
30 Jun 181,36012818465
31 Mar 181,29411917651
31 Dec 171,30612218544
31 Dec 161,035832160
31 Dec 151,021791960
31 Dec 14987221410

Quality Earnings: 603301 has a high level of non-cash earnings.

Growing Profit Margin: Insufficient data to determine if 603301's profit margins have improved over the past year.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if 603301's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Insufficient data to compare 603301's past year earnings growth to its 5-year average.

Earnings vs Industry: Insufficient data to determine if 603301's earnings growth over the past year exceeded the Medical Equipment industry average.


Return on Equity

High ROE: 603301 has a negative Return on Equity (0%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.